|
MBNL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.43849426498855E-15 |
| Normal-vs-Stage2 |
2.68669999581306E-08 |
| Normal-vs-Stage3 |
2.74558153989801E-13 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.563200E-01 |
| Stage1-vs-Stage3 |
6.471400E-01 |
| Stage1-vs-Stage4 |
7.593600E-02 |
| Stage2-vs-Stage3 |
5.609000E-01 |
| Stage2-vs-Stage4 |
1.730770E-01 |
| Stage3-vs-Stage4 |
2.771200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.91369142754638E-12 |
| Normal-vs-Asian |
3.561400E-01 |
| Caucasian-vs-AfricanAmerican |
2.421800E-01 |
| Caucasian-vs-Asian |
4.038600E-01 |
| AfricanAmerican-vs-Asian |
2.878400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22044604925031E-16 |
| Normal-vs-Female |
1.62592161956354E-12 |
| Male-vs-Female |
9.952400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.2040999832268E-09 |
| Normal-vs-Age(41-60Yrs) |
1.79223302865239E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.058400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.131800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.878300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.881000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.408120E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.902160E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.80760000001445E-06 |
| Normal-vs-Grade 2 |
2.99760216648792E-15 |
| Normal-vs-Grade 3 |
1.68032254777017E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
4.199600E-01 |
| Grade 1-vs-Grade 3 |
3.948400E-01 |
| Grade 1-vs-Grade 4 |
9.452400E-01 |
| Grade 2-vs-Grade 3 |
9.045600E-01 |
| Grade 2-vs-Grade 4 |
1.154780E-01 |
| Grade 3-vs-Grade 4 |
1.211570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66666680456728E-12 |
| Normal-vs-ccB subtype |
1.91635596280548E-12 |
| ccA subtype-vs-ccB subtype |
3.540800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
8.839100E-03 |
| N0-vs-N1 |
6.367800E-01 |
|
|
